The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis

The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis

Show other versions (1)

**Background:** Persistence and adherence to disease-modifying therapies (DMTs) affects treatment efficacy and economic outcomes, both of which contribute to overall patient disease burden. Current literature suggests that patients with multiple sclerosis (MS) who adhere to DMT for 12 months have fe...

Full description

Bibliographic Details
Main Authors: Gabriel Pardo, Elmor D. Pineda, Carmen D. Ng, Daniel Sheinson, Nicole G. Bonine
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2022-04-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/jheor.2022.33288
Show all versions (2)

Similar Items